Permission to publish COVID-19 vaccine iDAPs

The request was partially successful.

Kenneth MacArthur

Dear Medicines and Healthcare products Regulatory Agency (MHRA),

It is now almost a year since you first communicated, via responses to FOI requests, your intention to publish interactive drug analysis profiles (iDAPs) for the COVID-19 vaccines. In a number of such responses (eg, https://www.whatdotheyknow.com/request/1...), you have spoken of the MHRA "seeking permission" to publish iDAPs.

Please can you confirm:
1) Who the MHRA needs to seek permission from.
2) Whether such permission has yet been sought, and, if so, when, or, if not, when you intend to seek it.

In responding, I would invite you to take note of the ICO's guidance document "Government policy (section 35)" (https://ico.org.uk/media/for-organisatio...), which states:

"In general, arm’s-length bodies [which the MHRA, as an executive agency, is] are created to deliver specialist services which do not require the day to day engagement of ministers, or which need to be independent of government. As only ministers can approve government policy, it follows that the day to day business of these bodies will not involve government policymaking. By delegating an activity to a body at arm’s length from ministers, the government has in effect signalled that the activity is considered operational or otherwise independent of government."

I would also draw your attention to ICO decision notice FS50420602 on this matter.

Yours faithfully,

Kenneth MacArthur

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Thank you for your email.  This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
We will respond to you as soon as possible. 
 
Please note that we may not respond if your query: 
 
• contains offensive language
• has already been answered in a previous reply to you
• is illegible
• is selling or promoting a product
• is for information only 
 
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, 
Canary Wharf, 
London 
E14 4PU
gov.uk/mhra
Stay connected 
 
For information on how the Agency uses your personal data and your data
protection rights, please see our three centres’ Privacy Notices: MHRA,
CPRD and NIBSC. 
 
The UK has left the EU, and the transition period ends on 31 December
2020. Ourguidance and information can be accessed here.

________________________________________ From: Kenneth MacArthur
<[FOI #819887 email]> Sent: Wednesday, January 5,
2022 1:24:26 PM To: MHRA Customer Services Subject: Freedom of Information
request - Permission to publish COVID-19 vaccine iDAPs Dear Medicines and
Healthcare products Regulatory Agency (MHRA), It is now almost a year
since you first communicated, via responses to FOI requests, your
intention to publish interactive drug analysis profiles (iDAPs) for the
COVID-19 vaccines. In a number of such responses (eg,
https://eur01.safelinks.protection.outlo...),
you have spoken of the MHRA "seeking permission" to publish iDAPs. Please
can you confirm: 1) Who the MHRA needs to seek permission from. 2) Whether
such permission has yet been sought, and, if so, when, or, if not, when
you intend to seek it. In responding, I would invite you to take note of
the ICO's guidance document "Government policy (section 35)"
(https://eur01.safelinks.protection.outlo...),
which states: "In general, arm’s-length bodies [which the MHRA, as an
executive agency, is] are created to deliver specialist services which do
not require the day to day engagement of ministers, or which need to be
independent of government. As only ministers can approve government
policy, it follows that the day to day business of these bodies will not
involve government policymaking. By delegating an activity to a body at
arm’s length from ministers, the government has in effect signalled that
the activity is considered operational or otherwise independent of
government." I would also draw your attention to ICO decision notice
FS50420602 on this matter. Yours faithfully, Kenneth MacArthur
------------------------------------------------------------------- Please
use this email address for all replies to this request:
[FOI #819887 email] Is [MHRA request email] the wrong
address for Freedom of Information requests to Medicines and Healthcare
Products Regulatory Agency? If so, please contact us using this form:
https://eur01.safelinks.protection.outlo...
Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:
https://eur01.safelinks.protection.outlo...
For more detailed guidance on safely disclosing information, read the
latest advice from the ICO:
https://eur01.safelinks.protection.outlo...
Please note that in some cases publication of requests and responses will
be delayed. If you find this service useful as an FOI officer, please ask
your web manager to link to us from your organisation's FOI page.

show quoted sections

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Our Ref: FOI 22/049

Dear Kenneth MacArthur,

RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000

Thank you for your enquiry which we received on 5th January 2022.

I confirm that your request is now being handled under the Freedom of Information Act and you should receive a reply within 20 working days from our date of receipt.

If you need to contact us again about this request, please quote the reference number above.

Please be aware that we publish FOIs replies and these are redacted and are located on our website at the following link below.
https://www.gov.uk/government/collection...

Kind Regards,

MHRA Customer Service Centre

Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU Telephone 0203 080 6000

show quoted sections

Kenneth MacArthur

Dear Medicines and Healthcare products Regulatory Agency,

It is now over 20 working days since I submitted this request. This is in excess of the time period specified in section 10(1) of the Freedom of Information Act 2000.

Please can you now respond to my request forthwith.

Yours faithfully,

Kenneth MacArthur

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Thank you for your email.  This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
We will respond to you as soon as possible. 
 
Please note that we may not respond if your query: 
 
• contains offensive language
• has already been answered in a previous reply to you
• is illegible
• is selling or promoting a product
• is for information only 
 
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, 
Canary Wharf, 
London 
E14 4PU
gov.uk/mhra
Stay connected 
 
For information on how the Agency uses your personal data and your data
protection rights, please see our three centres’ Privacy Notices: MHRA,
CPRD and NIBSC. 
 
The UK has left the EU, and the transition period ends on 31 December
2020. Ourguidance and information can be accessed here.

________________________________________ From: Kenneth MacArthur
<[FOI #819887 email]> Sent: Thursday, February 3,
2022 1:42:23 PM To: MHRA Customer Services Subject: Re: FOI 22/049 - RE:
Freedom of Information request - Permission to publish COVID-19 vaccine
iDAPs Dear Medicines and Healthcare products Regulatory Agency, It is now
over 20 working days since I submitted this request. This is in excess of
the time period specified in section 10(1) of the Freedom of Information
Act 2000. Please can you now respond to my request forthwith. Yours
faithfully, Kenneth MacArthur -----Original Message----- Our Ref: FOI
22/049 Dear Kenneth MacArthur, RE: REQUEST UNDER THE FREEDOM OF
INFORMATION ACT 2000 Thank you for your enquiry which we received on 5th
January 2022. I confirm that your request is now being handled under the
Freedom of Information Act and you should receive a reply within 20
working days from our date of receipt. If you need to contact us again
about this request, please quote the reference number above. Please be
aware that we publish FOIs replies and these are redacted and are located
on our website at the following link below.
https://eur01.safelinks.protection.outlo...
Kind Regards, MHRA Customer Service Centre Medicines and Healthcare
products Regulatory Agency 10 South Colonnade, Canary Wharf, London E14
4PU Telephone 0203 080 6000
------------------------------------------------------------------- Please
use this email address for all replies to this request:
[FOI #819887 email] Disclaimer: This message and
any reply that you make will be published on the internet. Our privacy and
copyright policies:
https://eur01.safelinks.protection.outlo...
For more detailed guidance on safely disclosing information, read the
latest advice from the ICO:
https://eur01.safelinks.protection.outlo...
Please note that in some cases publication of requests and responses will
be delayed. If you find this service useful as an FOI officer, please ask
your web manager to link to us from your organisation's FOI page.

show quoted sections

Kenneth MacArthur

Dear Medicines and Healthcare products Regulatory Agency,

It is now over 40 working days since I submitted this request. This is far in excess of the time period specified in section 10(1) of the Freedom of Information Act 2000.

Please can you confirm forthwith whether you intend to reply to this request.

Yours faithfully,

Kenneth MacArthur

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Thank you for your email.  This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
We will respond to you as soon as possible. 
 
Please note that we may not respond if your query: 
 
• contains offensive language
• has already been answered in a previous reply to you
• is illegible
• is selling or promoting a product
• is for information only 
 
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, 
Canary Wharf, 
London 
E14 4PU
gov.uk/mhra
Stay connected 
 
For information on how the Agency uses your personal data and your data
protection rights, please see our three centres’ Privacy Notices: MHRA,
CPRD and NIBSC. 
 
The UK has left the EU, and the transition period ends on 31 December
2020. Ourguidance and information can be accessed here.

________________________________________ From: Kenneth MacArthur
<[FOI #819887 email]> Sent: Thursday, March 3, 2022
9:58:52 AM To: MHRA Customer Services Subject: RE: FOI 22/049 - RE:
Freedom of Information request - Permission to publish COVID-19 vaccine
iDAPs Dear Medicines and Healthcare products Regulatory Agency, It is now
over 40 working days since I submitted this request. This is far in excess
of the time period specified in section 10(1) of the Freedom of
Information Act 2000. Please can you confirm forthwith whether you intend
to reply to this request. Yours faithfully, Kenneth MacArthur
-----Original Message----- Thank you for your email. This auto-response is
to inform you that your email has been received and will be reviewed by
our Customer Service Team. We will respond to you as soon as possible.
Please note that we may not respond if your query: • contains offensive
language • has already been answered in a previous reply to you • is
illegible • is selling or promoting a product • is for information only
Medicines and Healthcare products Regulatory Agency 10 South Colonnade,
Canary Wharf, London E14 4PU gov.uk/mhra Stay connected For information on
how the Agency uses your personal data and your data protection rights,
please see our three centres’ Privacy Notices: MHRA, CPRD and NIBSC. The
UK has left the EU, and the transition period ends on 31 December 2020.
Ourguidance and information can be accessed here.
________________________________________ From: Kenneth MacArthur <[FOI
#819887 email]> Sent: Thursday, February 3, 2022 1:42:23 PM To: MHRA
Customer Services Subject: Re: FOI 22/049 - RE: Freedom of Information
request - Permission to publish COVID-19 vaccine iDAPs Dear Medicines and
Healthcare products Regulatory Agency, It is now over 20 working days
since I submitted this request. This is in excess of the time period
specified in section 10(1) of the Freedom of Information Act 2000. Please
can you now respond to my request forthwith. Yours faithfully, Kenneth
MacArthur -----Original Message----- Our Ref: FOI 22/049 Dear Kenneth
MacArthur, RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000 Thank you
for your enquiry which we received on 5th January 2022. I confirm that
your request is now being handled under the Freedom of Information Act and
you should receive a reply within 20 working days from our date of
receipt. If you need to contact us again about this request, please quote
the reference number above. Please be aware that we publish FOIs replies
and these are redacted and are located on our website at the following
link below.
https://eur01.safelinks.protection.outlo...
Kind Regards, MHRA Customer Service Centre Medicines and Healthcare
products Regulatory Agency 10 South Colonnade, Canary Wharf, London E14
4PU Telephone 0203 080 6000
------------------------------------------------------------------- Please
use this email address for all replies to this request: [FOI #819887
email] Disclaimer: This message and any reply that you make will be
published on the internet. Our privacy and copyright policies:
https://eur01.safelinks.protection.outlo...
For more detailed guidance on safely disclosing information, read the
latest advice from the ICO:
https://eur01.safelinks.protection.outlo...
Please note that in some cases publication of requests and responses will
be delayed. If you find this service useful as an FOI officer, please ask
your web manager to link to us from your organisation's FOI page.
------------------------------------------------------------------- Please
use this email address for all replies to this request:
[FOI #819887 email] Disclaimer: This message and
any reply that you make will be published on the internet. Our privacy and
copyright policies:
https://eur01.safelinks.protection.outlo...
For more detailed guidance on safely disclosing information, read the
latest advice from the ICO:
https://eur01.safelinks.protection.outlo...
Please note that in some cases publication of requests and responses will
be delayed. If you find this service useful as an FOI officer, please ask
your web manager to link to us from your organisation's FOI page.

show quoted sections

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Dear Mr Kenneth MacArthur,

Thank you for your email.

Please see below links to recent decision notices on the Information Commissioner's Office website relating to Interactive Data Analysis Profile and these documents are available in the public domain.

https://ico.org.uk/media/action-weve-tak...

https://ico.org.uk/media/action-weve-tak...

https://ico.org.uk/media/action-weve-tak...

Kind Regards

MHRA Customer Experience Centre

Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU

show quoted sections

Kenneth MacArthur

Dear Medicines and Healthcare products Regulatory Agency,

Thank you for your message and for the links.

However, as I'm sure you would agree, a few links are not - in law or in any other way - a substitute for a response to my FOI request.

Almost 60 working days have gone by since I made the request without my receiving a response. This is in clear breach of section 10(1) of the Freedom of Information Act 2000.

Please can you now reply to my request forthwith.

Yours faithfully,

Kenneth MacArthur

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Thank you for your email.  This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
We will respond to you as soon as possible. 
 
Please note that we may not respond if your query: 
 
• contains offensive language
• has already been answered in a previous reply to you
• is illegible
• is selling or promoting a product
• is for information only 
 
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, 
Canary Wharf, 
London 
E14 4PU
gov.uk/mhra
Stay connected 
 
For information on how the Agency uses your personal data and your data
protection rights, please see our three centres’ Privacy Notices: MHRA,
CPRD and NIBSC. 
 
The UK has left the EU, and the transition period ends on 31 December
2020. Ourguidance and information can be accessed here.

________________________________________ From: Kenneth MacArthur
<[FOI #819887 email]> Sent: Monday, March 28, 2022
5:46:23 PM To: MHRA Customer Services Subject: RE: FOI 22/049 - RE:
Freedom of Information request - Permission to publish COVID-19 vaccine
iDAPs Dear Medicines and Healthcare products Regulatory Agency, Thank you
for your message and for the links. However, as I'm sure you would agree,
a few links are not - in law or in any other way - a substitute for a
response to my FOI request. Almost 60 working days have gone by since I
made the request without my receiving a response. This is in clear breach
of section 10(1) of the Freedom of Information Act 2000. Please can you
now reply to my request forthwith. Yours faithfully, Kenneth MacArthur
-----Original Message----- Dear Mr Kenneth MacArthur, Thank you for your
email. Please see below links to recent decision notices on the
Information Commissioner's Office website relating to Interactive Data
Analysis Profile and these documents are available in the public domain.
https://eur01.safelinks.protection.outlo...
https://eur01.safelinks.protection.outlo...
https://eur01.safelinks.protection.outlo...
Kind Regards MHRA Customer Experience Centre Medicines and Healthcare
products Regulatory Agency 10 South Colonnade, Canary Wharf, London E14
4PU -------------------------------------------------------------------
Please use this email address for all replies to this request:
[FOI #819887 email] Disclaimer: This message and
any reply that you make will be published on the internet. Our privacy and
copyright policies:
https://eur01.safelinks.protection.outlo...
For more detailed guidance on safely disclosing information, read the
latest advice from the ICO:
https://eur01.safelinks.protection.outlo...
Please note that in some cases publication of requests and responses will
be delayed. If you find this service useful as an FOI officer, please ask
your web manager to link to us from your organisation's FOI page.

show quoted sections

Kenneth MacArthur

Dear Medicines and Healthcare products Regulatory Agency,

Further to our exchange of messages last week, please can you confirm by the end of this week (ie, by 8 April 2022) whether you intend to respond to this FOI request.

Yours faithfully,

Kenneth MacArthur

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Thank you for your email.  This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
We will respond to you as soon as possible. 
 
Please note that we may not respond if your query: 
 
• contains offensive language
• has already been answered in a previous reply to you
• is illegible
• is selling or promoting a product
• is for information only 
 
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, 
Canary Wharf, 
London 
E14 4PU
gov.uk/mhra
Stay connected 
 
For information on how the Agency uses your personal data and your data
protection rights, please see our three centres’ Privacy Notices: MHRA,
CPRD and NIBSC. 
 
The UK has left the EU, and the transition period ends on 31 December
2020. Ourguidance and information can be accessed here.

________________________________________ From: Kenneth MacArthur
<[FOI #819887 email]> Sent: Monday, April 4, 2022
12:12:28 PM To: MHRA Customer Services Subject: RE: FOI 22/049 - RE:
Freedom of Information request - Permission to publish COVID-19 vaccine
iDAPs Dear Medicines and Healthcare products Regulatory Agency, Further to
our exchange of messages last week, please can you confirm by the end of
this week (ie, by 8 April 2022) whether you intend to respond to this FOI
request. Yours faithfully, Kenneth MacArthur

show quoted sections

Kenneth MacArthur

Dear Medicines and Healthcare products Regulatory Agency,

Can you please let me know whether you intend to respond to my FOI request of 5 January 2022.

If you do not intend to so respond, can you please let me know why.

Thanking you in advance.

Yours faithfully,

Kenneth MacArthur

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Thank you for your email.  This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
We will respond to you as soon as possible. 
 
Please note that we may not respond if your query: 
 
• contains offensive language
• has already been answered in a previous reply to you
• is illegible
• is selling or promoting a product
• is for information only 
 
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, 
Canary Wharf, 
London 
E14 4PU
gov.uk/mhra
Stay connected 
 
For information on how the Agency uses your personal data and your data
protection rights, please see our three centres’ Privacy Notices: MHRA,
CPRD and NIBSC. 
 
The UK has left the EU, and the transition period ends on 31 December
2020. Ourguidance and information can be accessed here.

________________________________________ From: Kenneth MacArthur
<[FOI #819887 email]> Sent: Tuesday, April 19, 2022
8:59:23 PM To: MHRA Customer Services Subject: RE: FOI 22/049 - RE:
Freedom of Information request - Permission to publish COVID-19 vaccine
iDAPs Dear Medicines and Healthcare products Regulatory Agency, Can you
please let me know whether you intend to respond to my FOI request of 5
January 2022. If you do not intend to so respond, can you please let me
know why. Thanking you in advance. Yours faithfully, Kenneth MacArthur
-----Original Message----- Thank you for your email. This auto-response is
to inform you that your email has been received and will be reviewed by
our Customer Service Team. We will respond to you as soon as possible.
Please note that we may not respond if your query: • contains offensive
language • has already been answered in a previous reply to you • is
illegible • is selling or promoting a product • is for information only
Medicines and Healthcare products Regulatory Agency 10 South Colonnade,
Canary Wharf, London E14 4PU gov.uk/mhra Stay connected For information on
how the Agency uses your personal data and your data protection rights,
please see our three centres’ Privacy Notices: MHRA, CPRD and NIBSC. The
UK has left the EU, and the transition period ends on 31 December 2020.
Ourguidance and information can be accessed here.
________________________________________ From: Kenneth MacArthur <[FOI
#819887 email]> Sent: Monday, April 4, 2022 12:12:28 PM To: MHRA Customer
Services Subject: RE: FOI 22/049 - RE: Freedom of Information request -
Permission to publish COVID-19 vaccine iDAPs Dear Medicines and Healthcare
products Regulatory Agency, Further to our exchange of messages last week,
please can you confirm by the end of this week (ie, by 8 April 2022)
whether you intend to respond to this FOI request. Yours faithfully,
Kenneth MacArthur
------------------------------------------------------------------- Please
use this email address for all replies to this request:
[FOI #819887 email] Disclaimer: This message and
any reply that you make will be published on the internet. Our privacy and
copyright policies:
https://eur01.safelinks.protection.outlo...
For more detailed guidance on safely disclosing information, read the
latest advice from the ICO:
https://eur01.safelinks.protection.outlo...
https://eur01.safelinks.protection.outlo...
Please note that in some cases publication of requests and responses will
be delayed. If you find this service useful as an FOI officer, please ask
your web manager to link to us from your organisation's FOI page.

show quoted sections

Kenneth MacArthur

Dear Medicines and Healthcare products Regulatory Agency,

I recently spoke on the phone to one of your colleagues, who promised to come back to me by e-mail on this request (FOI 22/049), in particular addressing the matter of by when you expect to be able to respond to the request.

Is it possible to provide me with that update?

Yours faithfully,

Kenneth MacArthur

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Thank you for your email.  This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
We will respond to you as soon as possible. 
 
Please note that we may not respond if your query: 
 
• contains offensive language
• has already been answered in a previous reply to you
• is illegible
• is selling or promoting a product
• is for information only 
 
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, 
Canary Wharf, 
London 
E14 4PU
gov.uk/mhra
Stay connected 
 
For information on how the Agency uses your personal data and your data
protection rights, please see our three centres’ Privacy Notices: MHRA,
CPRD and NIBSC. 
 
The UK has left the EU, and the transition period ends on 31 December
2020. Ourguidance and information can be accessed here.

________________________________________ From: Kenneth MacArthur
<[FOI #819887 email]> Sent: Thursday, May 26, 2022
3:47:37 PM To: MHRA Customer Services Subject: RE: FOI 22/049 - RE:
Freedom of Information request - Permission to publish COVID-19 vaccine
iDAPs Dear Medicines and Healthcare products Regulatory Agency, I recently
spoke on the phone to one of your colleagues, who promised to come back to
me by e-mail on this request (FOI 22/049), in particular addressing the
matter of by when you expect to be able to respond to the request. Is it
possible to provide me with that update? Yours faithfully, Kenneth
MacArthur -----Original Message----- Thank you for your email. This
auto-response is to inform you that your email has been received and will
be reviewed by our Customer Service Team. We will respond to you as soon
as possible. Please note that we may not respond if your query: • contains
offensive language • has already been answered in a previous reply to you
• is illegible • is selling or promoting a product • is for information
only Medicines and Healthcare products Regulatory Agency 10 South
Colonnade, Canary Wharf, London E14 4PU gov.uk/mhra Stay connected For
information on how the Agency uses your personal data and your data
protection rights, please see our three centres’ Privacy Notices: MHRA,
CPRD and NIBSC. The UK has left the EU, and the transition period ends on
31 December 2020. Ourguidance and information can be accessed here.
________________________________________ From: Kenneth MacArthur <[FOI
#819887 email]> Sent: Tuesday, April 19, 2022 8:59:23 PM To: MHRA Customer
Services Subject: RE: FOI 22/049 - RE: Freedom of Information request -
Permission to publish COVID-19 vaccine iDAPs Dear Medicines and Healthcare
products Regulatory Agency, Can you please let me know whether you intend
to respond to my FOI request of 5 January 2022. If you do not intend to so
respond, can you please let me know why. Thanking you in advance. Yours
faithfully, Kenneth MacArthur -----Original Message----- Thank you for
your email. This auto-response is to inform you that your email has been
received and will be reviewed by our Customer Service Team. We will
respond to you as soon as possible. Please note that we may not respond if
your query: • contains offensive language • has already been answered in a
previous reply to you • is illegible • is selling or promoting a product •
is for information only Medicines and Healthcare products Regulatory
Agency 10 South Colonnade, Canary Wharf, London E14 4PU gov.uk/mhra Stay
connected For information on how the Agency uses your personal data and
your data protection rights, please see our three centres’ Privacy
Notices: MHRA, CPRD and NIBSC. The UK has left the EU, and the transition
period ends on 31 December 2020. Ourguidance and information can be
accessed here. ________________________________________ From: Kenneth
MacArthur <[FOI #819887 email]> Sent: Monday, April 4, 2022 12:12:28 PM
To: MHRA Customer Services Subject: RE: FOI 22/049 - RE: Freedom of
Information request - Permission to publish COVID-19 vaccine iDAPs Dear
Medicines and Healthcare products Regulatory Agency, Further to our
exchange of messages last week, please can you confirm by the end of this
week (ie, by 8 April 2022) whether you intend to respond to this FOI
request. Yours faithfully, Kenneth MacArthur
------------------------------------------------------------------- Please
use this email address for all replies to this request: [FOI #819887
email] Disclaimer: This message and any reply that you make will be
published on the internet. Our privacy and copyright policies:
https://eur01.safelinks.protection.outlo...
For more detailed guidance on safely disclosing information, read the
latest advice from the ICO:
https://eur01.safelinks.protection.outlo...
https://eur01.safelinks.protection.outlo...
Please note that in some cases publication of requests and responses will
be delayed. If you find this service useful as an FOI officer, please ask
your web manager to link to us from your organisation's FOI page.
------------------------------------------------------------------- Please
use this email address for all replies to this request:
[FOI #819887 email] Disclaimer: This message and
any reply that you make will be published on the internet. Our privacy and
copyright policies:
https://eur01.safelinks.protection.outlo...
For more detailed guidance on safely disclosing information, read the
latest advice from the ICO:
https://eur01.safelinks.protection.outlo...
https://eur01.safelinks.protection.outlo...
Please note that in some cases publication of requests and responses will
be delayed. If you find this service useful as an FOI officer, please ask
your web manager to link to us from your organisation's FOI page.

show quoted sections

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

1 Attachment

Dear Mr MacArthur

Please find a response to your request for an internal review of FOI 22/049 attached.

Kind regards,

Chris
MHRA Customer Experience Centre
Communications and engagement team
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU
gov.uk/mhra
Stay connected
For information on how the Agency uses your personal data and your data protection rights, please see our three centres' Privacy Notices: MHRA, CPRD and NIBSC.

Read our guidance on coronavirus (COVID-19)

show quoted sections